Study of the Safety and Effectiveness of Rilonacept (IL-1 Trap) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Public ClinicalTrials.gov record NCT00609544. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind, Placebo-Controlled Safety and Preliminary Efficacy Study of IL-1 Trap (Rilonacept) Administered Subcutaneously in Subjects With Non Dialysis-Dependent Chronic Kidney Disease (NDD-CKD) and Anemia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Anemia of inflammation is a common complication in patients with chronic kidney disease (CKD). Patients with CKD and anemia of inflammation also exhibit decreased response to erythropoietic agents, even in the presence of adequate iron stores. This decreased responsiveness is associated with increased levels of proinflammatory cytokines. Rilonacept is being developed for the treatment of inflammatory disorders. This is a clinical research study to determine the safety and effectiveness of rilonacept for the treatment of anemia in inflamed patients with CKD who are not yet on dialysis.
Study identification
- NCT ID
- NCT00609544
- Recruitment status
- Withdrawn
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Not listed
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Apr 19, 2011
United States locations
- U.S. sites
- 27
- U.S. states
- 13
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Alexander City | Alabama | — | — |
| Not listed | Muscle Shoals | Alabama | — | — |
| Not listed | Cerritos | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Los Alampios | California | — | — |
| Not listed | Thousand Palms | California | — | — |
| Not listed | Colorado Springs | Colorado | — | — |
| Not listed | Lauderdale Lakes | Florida | — | — |
| Not listed | Pembroke Pines | Florida | — | — |
| Not listed | Tampa | Florida | — | — |
| Not listed | Blue Ridge | Georgia | — | — |
| Not listed | Jonesboro | Georgia | — | — |
| Not listed | Portland | Maine | — | — |
| Not listed | Queens | New York | — | — |
| Not listed | Mooresville | North Carolina | — | — |
| Not listed | Shelby | North Carolina | — | — |
| Not listed | Allentown | Pennsylvania | — | — |
| Not listed | Harrisburg | Pennsylvania | — | — |
| Not listed | Orangeburg | South Carolina | — | — |
| Not listed | Sumter | South Carolina | — | — |
| Not listed | Barlett | Tennessee | — | — |
| Not listed | Clarksville | Tennessee | — | — |
| Not listed | Collierville | Tennessee | — | — |
| Not listed | Crossville | Tennessee | — | — |
| Not listed | Memphis | Tennessee | — | — |
| Not listed | Ogden | Utah | — | — |
| Not listed | Falls Church | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00609544, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00609544 live on ClinicalTrials.gov.